Hempstract Analysis

Hempstract Pink Sheet Analysis Notes

The company had not issued any dividends in recent years. Hempstract had 1:100 split on the 20th of July 2006. Hempstract, Inc. produces and sells cannabidiol and cannabigerol solutions in the United States. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract is traded on OTC Exchange in the United States.The quote for Hempstract is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Hempstract check out https://www.hempstractlabs.com.

Hempstract Investment Alerts

Hempstract Profitablity

The company has Profit Margin (PM) of (0.35) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.4.

Hempstract Predictive Daily Indicators

Hempstract Debt to Cash Allocation

Hempstract currently holds 75 in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Hempstract has a current ratio of 1.14, suggesting that it is not liquid enough and may have problems paying out its financial obligations when due. Debt can assist Hempstract until it has trouble settling it off, either with new capital or with free cash flow. So, Hempstract's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hempstract sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hempstract to invest in growth at high rates of return. When we think about Hempstract's use of debt, we should always consider it together with cash and equity.

Hempstract Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Hempstract's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Hempstract, which in turn will lower the firm's financial flexibility.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Hempstract prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hempstract shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Hempstract. By using and applying Hempstract Pink Sheet analysis, traders can create a robust methodology for identifying Hempstract entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

If you are still planning to invest in Hempstract check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hempstract's history and understand the potential risks before investing.